Trial · NCT00424372
Results by group25
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 25
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Summary of Adverse Events | Pregabalin | Subjects with adverse events | 124 | subjects | |
| Summary of Adverse Events | Pregabalin | Subjects with serious adverse events | 14 | subjects | |
| Summary of Adverse Events | Pregabalin | Subjects with severe adverse events | 5 | subjects | |
| Summary of Adverse Events | Pregabalin | Subjects discontinued due to adverse events | 17 | subjects | |
| Summary of Adverse Events | Pregabalin | Dose reduced or temporary discontinuation | 34 | subjects | |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Sensory Score | Pregabalin | Baseline | 11.3 | Standard Deviation 7.0 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Sensory Score | Pregabalin | Week 52 | 5.1 | Standard Deviation 5.6 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Sensory Score | Pregabalin | Endpoint | 6.7 | Standard Deviation 7.1 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Sensory Score | Pregabalin | Change from Baseline to Endpoint | -4.8 | Standard Deviation 5.9 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Affective Score | Pregabalin | Baseline | 3.4 | Standard Deviation 3.1 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Affective Score | Pregabalin | Week 52 | 1.0 | Standard Deviation 1.8 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Affective Score | Pregabalin | Endpoint | 1.7 | Standard Deviation 2.7 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Affective Score | Pregabalin | Change from Baseline to Endpoint | -1.8 | Standard Deviation 2.8 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Total Score | Pregabalin | Baseline | 14.7 | Standard Deviation 9.7 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Total Score | Pregabalin | Week 52 | 6.1 | Standard Deviation 7.2 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Total Score | Pregabalin | Endpoint | 8.2 | Standard Deviation 9.6 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Total Score | Pregabalin | Change from Baseline to Endpoint | -6.5 | Standard Deviation 8.4 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Present Pain Intensity | Pregabalin | Baseline | 2.8 | Standard Deviation 1.0 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Present Pain Intensity | Pregabalin | Week 52 | 1.4 | Standard Deviation 0.9 | score on scale |
| Short-Form McGill Pain Questionnaire the Efficacy of Change: Present Pain Intensity | Pregabalin | Endpoint | 1.7 | Standard Deviation 1.1 | score on scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00424372/results